NCT00888329View on ClinicalTrials.gov

Aprepitant for Prevention of Postoperative Nausea and Vomiting in Elective Hysterectomy

PHASE4TerminatedINTERVENTIONAL

Enrollment

256

Participants

Timeline

Start Date

July 31, 2007

Primary Completion Date

October 31, 2011

Study Completion Date

October 31, 2011

Conditions

Postoperative Nausea and Vomiting

Interventions

DRUG

Aprepitant

40 mg administered orally with a sip of water prior to anesthesia induction.

DRUG

Placebo

Placebo

Trial Locations (1)

85054

Mayo Clinic, Phoenix

Sponsors

Lead Sponsor

All Listed Sponsors

lead

Mayo Clinic

OTHER